注册 登录  
 加关注
   显示下一条  |  关闭
温馨提示!由于新浪微博认证机制调整,您的新浪微博帐号绑定已过期,请重新绑定!立即重新绑定新浪微博》  |  关闭

Jackson二抗授权|蛋白|细胞因子

西宝生物科研试剂团队服务糖,寡糖,多糖及检测服务和原料供应。Jackson二抗

 
 
 

日志

 
 
关于我

R&D Systems公司细胞生物学,提供优质的蛋白质,抗体,ELISA试剂盒,实验室试剂,细胞因子.包括Novus Biologicals, BiosPacific, Tocris Bioscience, Boston Biochem和Bionostics. Jackson二抗中国授权代理

网易考拉推荐

cyclo [Arg-Gly-Asp-D-Phe-Lys 系列1mg ,5mg,10mg  

2014-09-05 15:12:53|  分类: 酶,蛋白质,肽 |  标签: |举报 |字号 订阅

  下载LOFTER 我的照片书  |


cyclo [Arg-Gly-Asp-D-Phe-Lys(Ac-SCH2CO)]  1mg
cyclo [Arg-Gly-Asp-D-Phe-Lys(PEG-PEG)]   
cyclo [Arg-Gly-Asp-D-Phe-Lys(Biotin)]   
cyclo (Arg-Gly-Asp-D-Phe-Lys)    "c(RGDfK)                                                                                 
(M.W. 603.68) C27H41N9O7
M. Kantlehner, P. Schaffner, D. Finsinger, J. Meyer, A. Jonczyk, B. Diefenbach, B. Nies, G. Hozemann, S.L. Goodman, and H. Kessler. Chembiochem., 1, 107 (2000).
R.J. Kok, A.J. Schraa, E.J. Bos, H.E. Moorlag, S.A. ?sgeirsdóttir, M. Everts, DK. Meijer, and G. Molema, Bioconjug. Chem., 13, 128 (2002)."
TEL: 137888991907   E-mail:TEL NO @163.COM
上海惠诚生物为广大科研用户提供科学仪器,试剂耗材等专业科研产品服务。
代理产品品牌有:Nu-chek、LKT、AccuStandard、APSC、MPBio、Sigma-Aldrich、NIST,Reagecon、Megazyme,LGC、Ultra,日本和光(WAKO)、Shodex,Dr.E、PSS ,Matreya,CaroteNature瑞典Larodan产品,Chromadex等。提供美国药典USP 、欧洲药典标 EDQM、加拿大TRC标准物质等
专业提供中草药单体标准品,HPLC 98%以上,20mg/瓶,及500mg、1g定制询价.
cyclo (Arg-Gly-Asp-D-Phe-Cys)    "c(RGDfC)
(M.W. 578.65) C24H34N8O7S
RGD Tumor Targeting Peptide (linker additions via Cys)
(Requires further derivatization before use)
C. Pattillo, F. Sari-Sarraf, R. Nallamothu, B. Moore, G. Wood, and M. Kiani, Experim. Clin.Therapeutics, Radiation Research Society Meeting (2005)"

cyclo (Arg-Gly-Asp-D-Phe-Glu)    "c(RGDfE)
(M.W. 604.63) C26H36N8O9
RGD Peptide for Radiolabeling and Imaging
(Requires further derivatization before use)
G. Thumshirn, U. Hersel, S.L. Goodman, and H. Kessler, Chem. Eur. J., 9, 2717 (2003).
T. Poethko, M. Schottelius, G. Thumshirn, U. Hersel, M. Herz, G. Henriksen, H. Kessler, M. Schwaiger, and H.J. Wester, J. Nucl. Med., 45, 892 (2004)."

cyclo (Arg-Gly-Asp-D-Phe-Glu)    "c(RGDfE)
(M.W. 604.63) C26H36N8O9
RGD Peptide for Radiolabeling and Imaging
(Requires further derivatization before use)
G. Thumshirn, U. Hersel, S.L. Goodman, and H. Kessler, Chem. Eur. J., 9, 2717 (2003).
T. Poethko, M. Schottelius, G. Thumshirn, U. Hersel, M. Herz, G. Henriksen, H. Kessler, M. Schwaiger, and H.J. Wester, J. Nucl. Med., 45, 892 (2004)."

cyclo [Arg-Gly-Asp-D-Phe-Lys(PEG-PEG)]    "c(RGDfK(PEG-PEG))
where PEG = 8-Amino-3,6-Dioxaoctanoic Acid
(M.W. 894.0) C39H63N11O13
RGD Peptide equipped with PEG spacers for more efficient binding to lipid surfaces
(Requires further derivatization before use)
P. Holig, M. Bach, T. Volkel, T. Nahde, S. Hoffmann, R. Muller, and R.E. Kontermann, Protein Engin. Design Selection, 17, 433 (2004)."
 
cyclo [Arg-Gly-Asp-D-Phe-Lys(Biotin-PEG-PEG)]    "c(RGDfK(Biotin-PEG-PEG))
where PEG = 8-Amino-3,6-Dioxaoctanoic Acid
(M.W. 1120.30) C49H77N13O15S
RGD Peptide equipped with a biotin reporting tag and PEG spacers for more efficient binding to lipid surfaces
D. Boturyn, J.-L. Coll, E. Garager, M.-C. Favrot, and P. Dumy, JACS, 126, 5730  C. Dolce, A. Vakani, L. Archer, J.A. Morris-Wiman, and L.S. Holliday, J. Dent. Res., 82, 682 (2003).
P. Holig, M. Bach, T. Volkel, T. Nahde, S. Hoffmann, R. Muller, and R.E. Kontermann, Protein Engin. Design Selection, 17, 433 (2004)."


cyclo [Arg-Gly-Asp-D-Phe-Lys(Ac-SCH2CO)]    "c[RGDfK (Ac-SCH2CO)]
(M.W. 719.82) C31H45N9O9S
RGD Peptide equipped with thioacetyl group for linking to liposomes
(Requires further derivatization and deprotection before use)
R.J. Kok, A.J. Schraa, E.J. Bos, H.E. Moorlag, S.A. Asgeirsdottir, M. Everts, D.K.F. Meijer, and G. Molema, Bioconjug. Chem., 13, 128 (2002).
R.M. Schiffelers, G.A. Koning,, T.L.M. ten Hagen, M.H.A.M. Fens, A.J. Schraa, A.P.C.A. Janssen, R.J. Kok, G. Molema, and G. Storm, J. of Controlled Release, 91, 115 (2003).
K. Darlak, R.B. Miller, M.S. Stack, A.F. Spatola, and R.D. Gray, J. Biol. Chem., 265, 5199 (1990)."


cyclo (Arg-Ala-Asp-D-Phe-Lys)    "c(RADfK)
(M.W. 617.71) C28H43N9O7
Negative Control RGD Peptide for PCI-3661-PI
P.K. Dubey, V. Mishra, S. Jain, S. Mahor, and S.P. Vyas, J. Drug Targeting, 12, 257 (2004)."


Control Peptide of cyclo (Arg-Gly-Asp-D-Tyr-Lys) (PCI-3662-PI)"
cyclo [Arg-Gly-Asp-D-Phe-Lys(Biotin)]    "c[RGDfK(Biotin)]
(M.W. 829.98) C37H55N11O9S                                                                                                                
D. Boturyn, J.-L. Coll, E. Garager, M.-C. Favrot, and P. Dumy, JACS, 126, 5730 (2004)."

cyclo [Arg-Gly-Asp-D-Phe-Lys(Biotin)]    "c[RGDfK(Biotin)]
(M.W. 829.98) C37H55N11O9S
D. Boturyn, J.-L. Coll, E. Garager, M.-C. Favrot, and P. Dumy, JACS, 126, 5730 (2004)."

cyclo [Arg-Gly-Asp-D-Phe-Lys(H-Ser)]    "cyclo [RGDfK(H-Ser)]
(M.W. 690.76) C30H46N10O9
alphavbeta3 Integrin Binding RGD Peptide
RGD Tumor Targeting Peptide
(Requires further derivatization before use)"


H-Glu[cyclo (Arg-Gly-Asp-D-Tyr-Lys)]2    "H-E[c(RGDyK)]2
(M.W. 1350.47) C59H87N19O18
RGD Tumor Targeting and Tumor Imaging Peptide
(Requires further derivatization before use)
Y. Wu, X. Zhang, Z. Xiong, Z. Cheng , D.R. Fisher, S. Liu, S.S. Gambhir, and X. Chen, J. Nucl. Med., 46, 1707 (2005).
X. Chen, S. Liu, Y. Hou, M. Tohme, R. Park, J.R. Bading, and P.S. Conti, Mol. Imaging Biol., 6, 350 (2004).
X. Chen, C. Plasencia, Y. Hou, and N. Neamati, J. Med. Chem., 48, 1098 (2005).
X. Chen, M. Tohme, R. Park, Y. Hou, J.R. Bading, and P.S. Conti, Mol. Imaging, 3, 96 (2004)."


DOTA-Glu-[cyclo (Arg-Gly-Asp-D-Phe-Lys)]2    "DOTA-E-[c(RGDfK)2]
(M.W. 1704.88) C75H113N23O23
alphavbeta3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide for Radiolabelling
(Requires further derivatization before use)
M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink, D.S. Edwards, M. Rajopadhye, H. Boonstra, F.H. Corstens, and O.C. Boerman, Cancer Res., 62, 6146 (2002).
X. Chen, S. Liu, Y. Hou, M. Tohme, R. Park, J.R. Bading, and P.S. Conti, Mol. Imaging Biol., 6, 350 (2004)."
DOTA-Glu-[cyclo (Arg-Gly-Asp-D-Phe-Lys)]2    "DOTA-E-[c(RGDfK)2]
(M.W. 1704.88) C75H113N23O23
alphavbeta3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide for Radiolabelling
(Requires further derivatization before use)
M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink, D.S. Edwards, M. Rajopadhye, H. Boonstra, F.H. Corstens, and O.C. Boerman, Cancer Res., 62, 6146 (2002).
X. Chen, S. Liu, Y. Hou, M. Tohme, R. Park, J.R. Bading, and P.S. Conti, Mol. Imaging Biol., 6, 350 (2004)."
H-Glu[cyclo (Arg-Gly-Asp-D-Phe-Lys)]2 Trifluoroacetate Salt    "E-[c(RGDfK)2]
Trifluoroacetate Salt
(M.W. 1318.47)C59H87N19O16
RGD Tumor Targeting and Tumor Imaging Peptide
Requires further derivatization before  use                                                                                             
M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink, D.S. Edwards, M. Rajopadhye, H. Boonstra, F.H. Corstens, and O.C. Boerman, Cancer. Res., 62, 6146 (2002).
Y. Wu, X. Zhang, Z. Xiong, Z. Cheng, D.R. Fisher, S. Liu, S.S. Gambhir, and X. Chen, J. Nucl. Med., 46, 1707 (2005)."
H-Glu[cyclo (Arg-Gly-Asp-D-Phe-Lys)]2 Trifluoroacetate Salt    "E-[c(RGDfK)2]
Trifluoroacetate Salt
(M.W. 1318.47)C59H87N19O16
M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink, D.S. Edwards, M. Rajopadhye, H. Boonstra, F.H. Corstens, and O.C. Boerman, Cancer. Res., 62, 6146 (2002).
Y. Wu, X. Zhang, Z. Xiong, Z. Cheng, D.R. Fisher, S. Liu, S.S. Gambhir, and X. Chen, J. Nucl. Med., 46, 1707 (2005)."
H-Glu[cyclo (Arg-Gly-Asp-D-Phe-Lys)]2 Trifluoroacetate Salt    "E-[c(RGDfK)2]
Trifluoroacetate Salt
(M.W. 1318.47)C59H87N19O16
 M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink, D.S. Edwards, M. Rajopadhye, H. Boonstra, F.H. Corstens, and O.C. Boerman, Cancer. Res., 62, 6146 (2002).
Y. Wu, X. Zhang, Z. Xiong, Z. Cheng, D.R. Fisher, S. Liu, S.S. Gambhir, and X. Chen, J. Nucl. Med., 46, 1707 (2005)."
H-Gly-Arg-Gly-Asp-Asn-Pro-OH    "GRGDNP
(M.W. 614.62) C23H38N10O10
Inhibitor of Cell Adhesion to Fibronectin
(peptide acids, esters, aldehydes, alcohols, head-to-tail cyclic peptides)
M.D. Pierschbacher and E. Ruoslahti, J. Biol. Chem., 262, 17294 (1987)."
H-Gly-Arg-Gly-Asp-Asn-Pro-OH    "GRGDNP
(M.W. 614.62) C23H38N10O10
Inhibitor of Cell Adhesion to Fibronectin
(peptide acids, esters, aldehydes, alcohols, head-to-tail cyclic peptides)
M.D. Pierschbacher and E. Ruoslahti, J. Biol. Chem., 262, 17294 (1987)."
H-Gly-Arg-Ala-Asp-Ser-Pro-OH    "GRADSP
(M.W. 601.62) C23H39N9O10
Negative Control for Fibronectin Inhibitors
D.G. Hoyt, J.M. Rusnak, R.J. Mannix, R.A. Modzelewski, C.S. Johnson, and J.S. Lazo, Cancer Res., 56, 4146 (1996)."
H-Gly-Arg-Ala-Asp-Ser-Pro-OH    "GRADSP
(M.W. 601.62) C23H39N9O10
Negative Control for Fibronectin Inhibitors
D.G. Hoyt, J.M. Rusnak, R.J. Mannix, R.A. Modzelewski, C.S. Johnson, and J.S. Lazo, Cancer Res., 56, 4146 (1996)."
cyclo (Arg-Gly-Asp-D-Tyr-Cys)    c(RGDyC)                                          (M.W. 594.65)  C24H34N8O8S
cyclo (Arg-Gly-Asp-D-Tyr-Cys)    c(RGDyC)                                           (M.W. 594.65)  C24H34N8O8S
cyclo (Arg-Ala-Asp-D-Tyr-Cys)    "c(RADyC)              C25H36N8O8S"
cyclo (Arg-Ala-Asp-D-Tyr-Cys)    "c(RADyC)              C25H36N8O8S"
cyclo (Arg-Gly-Asp-d-Phe-Lys)    "c(RGDfK)                                       
M. Kantlehner, P. Schaffner, D. Finsinger, J. Meyer, A. Jonczyk, B. Diefenbach, B. Nies, G. Hozemann, S.L. Goodman, and H. Kessler, Chembiochem., 1, 107 (2000).
R.J. Kok, A.J. Schraa, E.J. Bos, H.E. Moorlag, S.A. ?sgeirsdóttir, M. Everts, D.K. Meijer, and G. Molema, Bioconjug. Chem., 13, 128 (2002).

cyclo (Arg-Gly-Asp-d-Phe-Lys)    "c(RGDfK)                                                                          
M. Kantlehner, P. Schaffner, D. Finsinger, J. Meyer, A. Jonczyk, B. Diefenbach, B. Nies, G. Hozemann, S.L. Goodman, and H. Kessler, Chembiochem., 1, 107 (2000).
R.J. Kok, A.J. Schraa, E.J. Bos, H.E. Moorlag, S.A. ?sgeirsdóttir, M. Everts, D.K. Meijer, and G. Molema, Bioconjug. Chem., 13, 128 (2002)."
cyclo (Arg-Gly-Asp-d-Phe-Lys)    "c(RGDfK)                
M. Kantlehner, P. Schaffner, D. Finsinger, J. Meyer, A. Jonczyk, B. Diefenbach, B. Nies, G. Hozemann, S.L. Goodman, and H. Kessler, Chembiochem., 1, 107 (2000).
R.J. Kok, A.J. Schraa, E.J. Bos, H.E. Moorlag, S.A. ?sgeirsdóttir, M. Everts, D.K. Meijer, and G. Molema, Bioconjug. Chem., 13, 128 (2002)."
H-Arg-Gly-Asp-Ser-Lys-OH    "RGD Tumor Targeting Peptide
S. Jasseron, C. Contino-Pepin, J.C. Maurizis, M. Rapp, B. Pucci, Bioorganic & Medicinal Chemistry Letters, 12, 7, (2002).
S. Jasseron, C. Contino-Pepin, J.C. Maurizis, M. Rapp, B. Pucci, Eur J Med Chem, 38, 9, (2003)."
H-Arg-Gly-Asp-Ser-Lys-OH    "RGD Tumor Targeting Peptide
S. Jasseron, C. Contino-Pepin, J.C. Maurizis, M. Rapp, B. Pucci, Bioorganic & Medicinal Chemistry Letters, 12, 7, (2002).
S. Jasseron, C. Contino-Pepin, J.C. Maurizis, M. Rapp, B. Pucci, Eur J Med Chem, 38, 9, (2003)."
H-Arg-Ala-Asp-Ser-Lys-OH    RADSK                                             
H-Arg-Ala-Asp-Ser-Lys-OH    RADSK                                     
cyclo (Arg-Gly-Glu-d-Phe-Lys)    c(RGEfK)
cyclo (Arg-Gly-Glu-d-Phe-Lys)    c(RGEfK)
cyclo (Arg-Gly-Glu-d-Phe-Lys)    c(RGEfK)
  评论这张
 
阅读(654)| 评论(0)
推荐 转载

历史上的今天

在LOFTER的更多文章

评论

<#--最新日志,群博日志--> <#--推荐日志--> <#--引用记录--> <#--博主推荐--> <#--随机阅读--> <#--首页推荐--> <#--历史上的今天--> <#--被推荐日志--> <#--上一篇,下一篇--> <#-- 热度 --> <#-- 网易新闻广告 --> <#--右边模块结构--> <#--评论模块结构--> <#--引用模块结构--> <#--博主发起的投票-->
 
 
 
 
 
 
 
 
 
 
 
 
 
 

页脚

网易公司版权所有 ©1997-2017